Sanofi (EPA:SAN)
77.27
-0.46 (-0.59%)
Mar 6, 2026, 12:25 PM CET
Sanofi Employees
Sanofi had 74,846 employees as of December 31, 2025. The number of employees decreased by 8,032 or -9.69% compared to the previous year.
Employees
74,846
Change (1Y)
-8,032
Growth (1Y)
-9.69%
Revenue / Employee
€624,162
Profits / Employee
€104,388
Market Cap
93.86B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 74,846 | -8,032 | -9.69% |
| Dec 31, 2024 | 82,878 | -3,210 | -3.73% |
| Dec 31, 2023 | 86,088 | -5,485 | -5.99% |
| Dec 31, 2022 | 91,573 | -3,869 | -4.05% |
| Dec 31, 2021 | 95,442 | -3,970 | -3.99% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| EssilorLuxottica Société anonyme | 200,000 |
| Sartorius Stedim Biotech | 10,265 |
| Ipsen | 5,358 |
| Eurofins Scientific SE | 65,000 |
| bioMérieux | 14,754 |
| ABIVAX Société Anonyme | 67 |
| Virbac | 6,365 |
| emeis Société anonyme | 83,500 |
Sanofi News
- 1 day ago - Press Release: Sanofi's Board of Directors proposes the appointment of Christel Heydemann as an independent director - GlobeNewsWire
- 1 day ago - Press Release: Filing of an amendment to the French "Document d'Enregistrement Universel" containing the Annual Financial Report - Benzinga
- 1 day ago - Press Release: Filing of an amendment to the French “Document d'Enregistrement Universel” containing the Annual Financial Report - GlobeNewsWire
- 1 day ago - Sino Biopharmaceutical (SBHMY) Strikes $1.53B Deal with Sanofi for Cancer Drug - GuruFocus
- 1 day ago - Sanofi bets up to $1.53B to license blood cancer drug from Sino Biopharma unit - Seeking Alpha
- 2 days ago - Sino Biopharm unit licenses blood cancer drug to Sanofi for up to $1.53 bln - Reuters
- 3 days ago - Zacks Industry Outlook Highlights Eli Lilly, Johnson & Johnson, Sanofi and Bayer - Nasdaq
- 3 days ago - 4 Large-Cap Pharma Stocks to Watch as Industry Recovery Gains Steam - Nasdaq